This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Learn about no annual fee credit cards that allow you to earn points. Start benefiting from your spending today!
25,023 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
If I had just $500 to invest in the AI wave, I’d narrow it to one strong option. This guide explains why and how to m...
Big tech often steals the AI spotlight, but overlooked, nimble players could outperform. This guide breaks down the r...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
A key Michigan district flipped Democrat in a special election, signaling rising concern over inflation and auto tari...
Ethereum has struggled to clear its late-2025 highs, with on-chain data showing a wave of whale selling even as ETF i...
UBS analysts warn that aging housing stock could spark a repair-driven upcycle for major home-improvement retailers. ...
As the Q1 2026 earnings transcript approaches, investors look for how Millicom will balance growth across mobile serv...
The latest wage and price data confirm a sharp uptick in everyday costs as grocery and restaurant prices post a notab...
The 2026 HousingWire Homebuilder Rankings broaden the field, adding new metrics that measure profitability and local ...
Non-hyperscaler AI infrastructure plays are delivering robust quarterly results as data-center demand remains strong,...